02.25.26 -- End-To-End ADC Manufacturing Works Best With Active Sponsor Oversight

In this on-demand webinar, our manufacturing experts provide insights into the growing ophthalmic market and how to optimize your drug development research outcomes.

Uncover how mesoporous silica can streamline micronization by improving powder flow, reducing run time, and increasing yield, offering a powerful enhancement to particle-size reduction processes.

Tackling high turnover and employee equity challenges is a priority. Learn how an on-site insourcing solution can provide a stable and motivated team, ensuring project success.

From formulation challenges to scale-up and commercialization, proactive planning and capabilities help teams anticipate risks, accelerate decision-making, and maintain momentum across development.

The session highlights the use of phosphonic acid anhydride reagent in amidation and peptide-coupling reactions across both liquid-phase and solid-phase peptide synthesis.

Focusing on solvent management is key to minimizing energy consumption in synthesis. By reducing or replacing solvents, chemists significantly cut both hazardous waste and process energy use.

Precision‑medicine formulation needs targeted design, adaptable workflows, and strong science. Thoughtful approaches improve performance, support patient needs, and help therapies advance.

Regulators are increasingly favoring in vitro methods to prove bioequivalence, though differing guidelines and a new focus on matching reference product structures pose challenges.